For instance, ATRA exerts a significant anti-tumor action on TNBC (Triple Negative Breast Cancer) cells characterized by constitutive activation of the NOTCH1 (Neurogenic locus NOTCH Homolog protein 1) cell membrane receptor. The gene discussed is NOTCH1; the disease is neoplasm.